GSK's $2.2B Purchase of RAPT Signals Pharma's Growing Stake in Allergy Treatment

GlaxoSmithKline's acquisition of RAPT Pharmaceuticals highlights the pharmaceutical industry's push towards innovative solutions for critical health issues such as food allergies.